Related Experiment Video
Updated: Jan 25, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1
Huan He1, Dandan Song1, Indranil Sinha1
1Department of Biosciences and Nutrition, Karolinska Institutet, S-141 83, Huddinge, Sweden.
Abstract:
Fra-1, a member of the activator protein 1 (AP-1) family, is overexpressed in triple-negative breast cancer (TNBC) and plays crucial roles in tumor growth. Here we report the identification of 118 proteins interacting with endogenous chromatin-bound Fra-1 in TNBC cells, highlighting DDX5 as the most enriched Fra-1-interacting protein. DDX5, a previously unrecognized protein in the Fra-1 transcriptional network, shows extensive overlap with Fra-1 cistrome and transcriptome that are highly associated with the TNBC cell growth. We provide evidence that DDX5 expression enhances Fra-1 transcriptional activity and potentiates Fra-1-driven cell proliferation. Furthermore, we show that the DDX5 target gene signature predicts poor clinical outcome in breast cancer patients. DDX5 protein level was higher in triple-negative basal-like tumors than in non-basal-like tumors, including luminal A, luminal B, and HER2-enriched subtypes. Collectively, by combining proteomic and genomic approaches we reveal a role for DDX5 as a regulatory protein of Fra-1 signaling and suggest DDX5 as a potential therapeutic target for TNBC.
Insights
The activator protein 1 (AP-1) family member Fra-1 is overexpressed in triple-negative breast cancer (TNBC). Researchers identified DDX5 as a key interacting protein, revealing DDX5 as a potential therapeutic target for TNBC.
Area of Science:
- Molecular Biology
- Oncology
- Proteomics
Background:
- Fra-1, a member of the activator protein 1 (AP-1) family, is overexpressed in triple-negative breast cancer (TNBC).
- Fra-1 plays crucial roles in tumor growth and progression within TNBC.
- The precise molecular mechanisms governing Fra-1's function in TNBC are not fully elucidated.
Purpose of the Study:
- To identify proteins interacting with endogenous chromatin-bound Fra-1 in TNBC cells.
- To investigate the functional role of DDX5 in Fra-1 transcriptional activity and TNBC cell proliferation.
- To evaluate DDX5 as a potential therapeutic target for TNBC.
Main Methods:
- Proteomic analysis to identify Fra-1 interacting proteins.
- Chromatin immunoprecipitation sequencing (ChIP-seq) and RNA sequencing (RNA-seq) to analyze Fra-1 and DDX5 cistromes and transcriptomes.
- Functional assays to assess the impact of DDX5 on Fra-1 activity and cell proliferation.
- Analysis of DDX5 expression in breast cancer patient cohorts.
Main Results:
- 118 proteins were identified interacting with Fra-1, with DDX5 being the most enriched.
- DDX5 shows extensive overlap with Fra-1 cistrome and transcriptome, correlating with TNBC cell growth.
- DDX5 expression enhances Fra-1 transcriptional activity and potentiates Fra-1-driven proliferation.
- A DDX5 target gene signature predicts poor clinical outcomes in breast cancer patients.
- DDX5 protein levels are significantly higher in triple-negative basal-like tumors compared to other subtypes.
Conclusions:
- DDX5 is a novel regulator of Fra-1 signaling in TNBC.
- DDX5 potentiates Fra-1-driven TNBC cell growth and proliferation.
- DDX5 represents a promising potential therapeutic target for triple-negative breast cancer.
More Related Videos
11:25Enhanced Yeast One-hybrid Screens To Identify Transcription Factor Binding To Human DNA Sequences
Published on: February 11, 2019
07:48Genome-wide Profiling of Transcription Factor-DNA Binding Interactions in Candida albicans: A Comprehensive CUT&RUN Method and Data Analysis Workflow
Published on: April 1, 2022
Related Concept Videos
Transcription Factors
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
Transcription Elongation Factors
General Transcription Factors
Transcription
Transcription is the process of synthesizing RNA from a DNA sequence by RNA polymerase. It is the first step in producing a protein from a gene sequence. Additionally, many other proteins and regulatory sequences are involved in the proper synthesis of messenger RNA (mRNA). Regulation of transcription is responsible for the differentiation of all the different types of cells and often for the proper cellular response to environmental signals.
Transcription Can Produce Different Kinds...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...